Go to content

Publications

484 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:

  1. Background report on assessing established medical science and medical practice in repetitive transcranial magnetic stimulation (rTMS) in depression

    The existing literature provides insufficient data to be able to decide whether there is a place for rTMS in the standard of care ...

    Report | 24-06-2011

  2. Fluoride application on milk teeth

    CVZ has carried out literature research into the question as to whether the professional application of fluoride to children who ...

    Report | 24-06-2011

  3. Physical therapy and exercise in cases of chronic arthritis

    CVZ concludes that there is no evidence for the efficacy of longterm physical therapy and exercise therapy in cases of chronic ...

    Report | 30-05-2011

  4. Physical therapy and exercise in cases of osteoporosis

    CVZ concludes that long-term physical therapy and exercise therapy for the indication “ vertebral fracture as a result of ...

    Report | 30-05-2011

  5. Physical therapy and exercise in cases of arthrosis

    CVZ concludes that there is no evidence for the efficacy of longterm physical therapy and exercise therapy in cases of chronic ...

    Report | 30-05-2011

  6. Ticagrelor (Brilique) for the prevention of atherothrombotic events in adult patients with acute coronary syndromes

    Patients treated with ticagrelor + ASA had a 22% reduced risk of all-cause mortality in comparison with patients treated with ...

    Report | 23-05-2011

  7. Calcium acetate-magnesium carbonate (OsvaRen) for hyperphosphatemia

    The Committee maintains her verdict that the therapeutic value of OsvaRen is comparable with that calcium acetate. This report is ...

    Report | 23-05-2011

  8. Ofatumumab (Arzerra) for Chronic Lymphatic Leukaemia

    The orphan drug ofatumumab demonstrated a high objective response in patients who are refractory for fludarabine and alemtuzumab. ...

    Report | 23-05-2011

  9. Treating MS-CCSVI by cerebrospinal vein dilatation is medical science and practice

    The basis for using venous angioplasty as a treatment for multiple sclerosis (MS), is the presumed pathophysiological mechanism ...

    Report | 23-05-2011

  10. Aztreonam (Cayston) Summary of therapeutic value

    For the treatment of adult patients with cystic fibrosis and a chronic P. aeruginosa infection, the inhalation of aztreonam has ...

    Report | 18-04-2011

Go to